abstract |
The present invention relates to novel hydroxylethylamine compounds having Asp2 (β-secretase, BACE1 or memapsin) inhibitory activity, methods for their preparation, compositions containing them and diseases characterized by high β-amyloid levels or β-amyloid deposition, In particular it relates to its use in the treatment of Alzheimer's disease. |